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https://doi.org/10.1016/j.stemcr.2017.09.019SUMMARYEmbryonic stem cells (ESCs) cultured in leukemia inhibitory factor (LIF) plus fetal bovine serum (FBS) exhibit heterogeneity in the expres-
sion of naive and primed transcription factors. This heterogeneity reflects the dynamic conditionof ESCs and their versatility to promptly
respond to signaling effectors promoting naive or primed pluripotency. Here, we report that ESCs lacking Nanog or overexpressing Otx2
exhibit an early primed identity in LIF + FBS and fail to convert into 2i-induced naive state. Conversely, Otx2-null ESCs possess naive
identity features in LIF + FBS similar to Nanog-overexpressing ESCs and convert poorly into FGF-induced early primed state. When
bothNanog andOtx2 are inactivated, ESCs cultured in LIF + FBS exhibit primed identity and weakened ability to convert into naive state.
These data suggest that, throughmutual antagonism,NANOGandOTX2 specify the heterogeneous identity of ESCs cultured in LIF + FBS
and individually predispose them for optimal response to naive or primed inducing factors.INTRODUCTION
Pluripotency is the capability of a single cell to generate
all embryonic and adult cell types. In vivo this ability is
exhibited by the epiblast, and in vitro by pluripotent stem
cells (Nichols and Smith, 2009; Rossant and Tam, 2009;
Gardner and Beddington, 1988). Mouse ESCs may be
derived from both the inner cell mass and early preimplan-
tation epiblast; they can be indefinitely propagated in
culture by ensuring provision of leukemia inhibitory factor
(LIF) plus fetal bovine serum (FBS) andmay efficiently inte-
grate into host blastocysts and contribute to all body tissues
(Nichols and Smith, 2009; Silva and Smith, 2008; Martin,
1981; Evans and Kaufman, 1981). However, their state
depends strictly on a regulatory network controlled by
core pluripotency transcription factors OCT4, SOX2,
KLF2/4, NANOG, and ESRRB as well as LIF, WNT, and
BMP4 signaling pathways (Kalkan and Smith, 2014;
Festuccia et al., 2012; Martello et al., 2012; ten Berge et al.,
2011; Silva et al., 2009; Ying et al., 2008). ESCs cultured in
LIF + FBS are characterized by cell heterogeneity in both
expression of specific transcription factors and sensitivity
to signaling molecules, which together define a state
ensuring self-renewal and opportunity to convert into
naive or primed pluripotency. This cell heterogeneity is
exemplified by the fluctuating expression of Nanog and by
the detection of naive and primed markers in specific ESC
sub-type compartments (Smith, 2017; Acampora et al.,
2013, 2016; Torres-Padilla and Chambers, 2014; Cahan1642 Stem Cell Reports j Vol. 9 j 1642–1659 j November 14, 2017 j ª 2017
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calzo et al., 2012; Nichols and Smith, 2011; Kalmar et al.,
2009; Hayashi et al., 2008; Chambers et al., 2007). A similar
heterogeneity exists in the preimplantationmouse embryo
at E4.5–E4.7 when the epiblast gradually loses naive
identity and begins to induce early primed pluripotency
(Acampora et al., 2016). Recently, the state of the early
primed epiblast has been discussed as representing a new
phase of pluripotency, named formative, which is inter-
posed between naive and primed pluripotency (Smith,
2017). Formative pluripotency is hypothesized to represent
an essential staging post required to enable naive cells to
successfully remodel transcriptional, epigenetic, signaling,
and metabolic networks in preparation for transit into a
mature primed state responsive to differentiation cues
(Smith, 2017). ESCs cultured inLIF + FBSmaybe committed
to naive or primed pluripotency if adequately stimulated.
For example, ESCs cultured in LIF may convert into a naive
state of pluripotency if provided with the two inhibitor
molecules (2i), which respectively inhibit FGF signaling
and activate WNT signaling (Marks et al., 2012; Nichols
et al., 2009; Ying et al., 2008); alternatively ESCs may
also convert to a primed state of pluripotency if LIF is re-
placed with FGF and Activin A (Kunath, 2011; Lanner and
Rossant, 2010; Brons et al., 2007; Tesar et al., 2007).
Signaling-pathway-mediated modification of the pluripo-
tent state is associated with a response in the expression
of specific genes, which ultimately determine the state of
pluripotency. This implies that the precise dosage andThe Authors.
ecommons.org/licenses/by-nc-nd/4.0/).
relationship between pluripotency factors should deter-
mine optimal functioning of the entire circuitry (Smith,
2017; Torres-Padilla andChambers, 2014; Karwacki-Neisius
et al., 2013; Mun˜oz Descalzo et al., 2012; Takahashi and
Yamanaka, 2006; Niwa et al., 2000). For example, Nanog
overexpression is sufficient to drive LIF-independent self-
renewal, and the gene dosage of Nanog determines the
efficiency with which ESCs can self-renew (Chambers
et al., 2007). Nanog null ESCs, although predisposed to
differentiate, retain an undifferentiated phenotype and
ability to self-renew (Theunissen et al., 2011; Silva et al.,
2009; Chambers et al., 2003, 2007; Mitsui et al., 2003). On
the other hand, OTX2 opposes LIF-independent self-
renewal, is required for transition into early primed plurip-
otency, and stabilizes the EpiSC state (Buecker et al., 2014;
Yang et al., 2014; Acampora et al., 2013). OTX2 may also
bind to the Nanog promoter and positively sustain Nanog
expression to optimize in vivo the specification of the
epiblast and in vitro the integrity of ESC sub-type compart-
ments (Acampora et al., 2016).Wehypothesize that integra-
tion of the OTX2 and NANOG antagonistic networks
specifies the heterogeneous identity of ESCs cultured in
LIF + FBS. To gain insights into this mechanism, we studied
whether different dosages of OTX2 and/or NANOG may
intrinsically modify the pluripotent state of ESCs cultured
in LIF + FBSwithout the contribution of signaling effectors.
Our data suggest that OTX2 and NANOG cooperate to
deliver the heterogeneous and flexible identity of ESCs
cultured in LIF + FBS from their antagonistic regulatory
networks.RESULTS
OTX2 and NANOG Antagonism Controls the
Specification of ESC Sub-types Cultured in LIF + FBS
Werecently reported that the combinedanalysis ofNANOG,
OCT6, and OTX2 protein expression identified five OCT4+
compartments in ESCs cultured in LIF + FBS. In addition to
a large naive-like (NANOG+-OTX2-OCT6) and a small
primed-like (NANOG-OTX2+-OCT6+) compartment, three
potentially transitional compartments were identified that
we refer to as pre-naive-like (NANOG+-OTX2+-OCT6),
pre-primed-like (NANOG-OTX2-OCT6+), and unassigned
(NANOG-OTX2+-OCT6) (Acampora et al., 2016). To test
our hypothesis that the antagonism between the OTX2
and NANOG regulatory networks coordinates the specifica-
tion of ESC compartments, we analyzed the expression of
these transcription factors in a new allelic series of ESC
mutant lines, which have different gene dosages of Otx2
and/orNanog, includingNanognull andOtx2null ESC lines.
We first targeted CreER into the Rosa26 locus of wild-type
(WT) ESCs (R26CreER/+) and used this ESC line to generate allmutant ESCs (Figure S1). To monitor expression from the
Nanog locus in Nanog null ESCs (NanogCh/; R26CreER/+
referred to as NanogKO) mCherry (Ch) was inserted into
one of the Nanog alleles. To generate the NanogKOmutant,
Nanogflox/Ch; R26CreER/+ (referred to as NanogCKO) ESCs
(Figures S1A–S1C) were plated at clonal density and treated
with 4-OH-tamoxifen (Tx) 3 hr later. Only very few
NanogKO clones could be cultured (Figure S2A) for more
than 12 passages (P12). Although these clones generated
abundant OCT4 cells with primitive endoderm (PE)-like
identity, they also exhibited numerous small and flat
OCT4+ colonies (Figures S2B and S2C) (Mitsui et al.,
2003). These OCT4+ cells accounted for 13% of total cells
(Figures S2E and S3A; Table S1).We next analyzed the iden-
tity of OCT4+ cells by monitoring the expression of CH,
KLF4, OTX2, and OCT6. Cell-counting experiments
showed that compared with WT, in NanogKO ESCs the
number of OCT4+ cells expressing CH or KLF4 was severely
decreased, while that of OTX2 andOCT6 increased (Figures
S2D, S2F, and S3A; Table S1). OCT4+ ESCs were then
analyzed for co-expression of OCT6, CH, and OTX2.
Compared with WT, in NanogKO ESCs the naive-like and
the pre-naive-like compartments were heavily reduced,
and the primed-like compartment markedly expanded
(Figures S2G and S3B; Table S1). Noteworthy, the sum of
all compartments accounted for the expected percentage
of OCT4+ ESCs (Figure S2H). This indicates that the cell-
counting analysis is not excluding OCT4+ ESC sub-types
negative for CH, OTX2, and OCT6 expression. These data
revealed that loss of Nanog causes a marked expansion of
the primed-like compartment at the expense of the naive-
like and pre-naive-like compartments (Figure S2I). Based
on this, we reasoned that, despite the large expansion of
the primed-like sub-type, a fraction of NanogKO ESCs
retained naive-like and pre-naive-like identity, suggesting
that CH+ ESCs may include a fraction of cells protected
from conversion into primed-like identity. To test this pos-
sibility, we sortedCH+ ESCs (Figure 1A) fromNanogKO ESCs
and studied whether these NanogKO sorted (NanogKOS)
ESCs generated colonies with a different identity. Alkaline
phosphatase (ALP) assay showed that none of the
NanogKOS ESC colonies was uniformly ALP+, but most of
them retained an evident mixed staining (Figure 1B).
Immunohistochemistry assays and cell counting showed
that compared with NanogKO ESCs, NanogKOS ESCs gener-
ated much less PE-like OCT4 cells (Figures 1C, 1D, S2B,
S2C, and S4A) and showed a remarkable increase in the per-
centage of total cells expressing OCT4 (Figures 1F and S2E;
Table S1). Cell counting showed that in NanogKOS ESCs,
the number of CH+ and KLF4+ cells was decreased
compared with WT ESCs but increased compared with
NanogKO ESCs; in a complementary trend, the number of
OCT6+ and OTX2+ cells in NanogKOS ESCs was increasedStem Cell Reports j Vol. 9 j 1642–1659 j November 14, 2017 1643
Figure 1. NanogKOS ESCs Exhibit Partial Recovery of Naive-like and Pre-naive-like ESC Sub-types
(A) Flow cytometry plot of NanogKO ESCs showing CH+ cells versus side scatter (SSC).
(B) Number of WT and NanogKOS colonies uniformly ALP+. Data are the means ± SD from four independent experiments.
(legend continued on next page)
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compared with WT ESCs but diminished compared with
NanogKO ESCs (Figures 1G, S2F, and S3A; Table S1). Anal-
ysis of NanogKOS sub-types showed that, compared with
WT, the naive-like compartment was severely reduced,
the pre-naive-like compartment was unaffected, and the
unassigned, pre-primed-like, and primed-like compart-
ments were expanded (Figures 1H and 1K). Compared
with NanogKO, the size of the naive-like, pre-naive-like
and primed-like compartments of NanogKOS ESCs was
partially restored (Figures 1K and S2I). Coherently, com-
pared with NanogKO, in NanogKOS ESCs the expression of
Fgf4, Rex1, and Esrrb was moderately increased and that
of Oct6 and Fgf5 decreased (Figures 1J and S4B) (Chambers
et al., 2007). These data suggest that the inactivation of
Nanog has a remarkable impact on the identity of OCT4+
ESCs, which become shifted toward the primed-like
identity (Figure S2I). Our analysis also reveals that the
CH+ ESC fraction is protected from complete conversion
into primed-like identity (Figure 1K).
Since we initially hypothesized that NANOG and OTX2
act through reciprocal antagonism to control the state of
ESCs cultured in LIF + FBS, we next studied mutant ESCs
lacking Nanog in an Otx2 null background (NanogCh/;
Otx2Gfp/; R26CreER/+ referred to as DKO) in comparison
with NanogCh/+; Otx2Gfp/+; R26CreER/+ (referred to as DHet)
and Otx2Gfp/; R26CreER/+ (referred to as Otx2KO) ESCs
(Figure S1). First, Nanogflox/Ch; Otx2Gfp/; Rosa26CreER/+
(referred to as NanogCKO; Otx2KO) (Figure S1D) ESCs
were plated at clonal density and with Tx to select DKO
ESCs. Importantly, about 80% of theDKO ESC clones could
be extensively and stably passaged (Figure 2A). Analysis
of ten of these clones showed flat colonies and no sign of
differentiation into PE-like cells (data not shown). This in-
dicates that loss of Nanog in an Otx2 null background pre-
vents both loss of efficient self-renewal and differentiation
into PE-like cells. We next monitored the ability of mutant
ESC lines to generate colonies uniformly stained with ALP.(C)Representative imagesofWTandP4NanogKOSESCs immunostainedw
(D) RT-PCR assays with Oct4 and PE (Gata6, Gata4, Sox17, Foxa2, an
(n = 3 independent experiments).
(E) Representative images of WT and NanogKOS ESCs immunostained
NANOG or CH, OTX2, and OCT6; ESCs are also stained with DAPI. Scale
(F–I) Cell-counting analysis showing in WT and NanogKOS ESCs the pe
cells expressing NANOG or CH, KLF4, OCT6, and OTX2 (G), the perc
unassigned, pre-primed-like, and primed-like identity (H), and the pe
Data are reported as means ± SD from four independent experiments.
(J) RT-PCR assays showing the expression of Nanog, Ch, Otx2, Fgf5,
normalized by Oct4 (n = 3 independent experiments).
(K) Schematic representation of ESC sub-type compartments show
compartment and moderate expansion of the unassigned, pre-primed
compartments is also shown.
See also Figures S1–S4 and Table S1.Compared with WT and DHet, DKO ESCs similar to
NanogKOS ESCs produced very few uniformly ALP+
colonies, whereas Otx2KO ESCs showed a higher number
of fully stained ALP+ colonies (Figure 2B) (Acampora
et al., 2013). Analysis of trypsinized living cells showed
that compared with DHet, the ratio between CH+ and
GFP+ cells is reversed in DKO ESCs (Figure 2C). Of note,
the CH+-GFP ESC subset was absent in DKO mutant
(Figure 2C). Cell counting of immunohistochemistry ex-
periments showed that OCT4 was ubiquitously expressed
in all mutant ESCs (Figures 2D and 3A). The number of
NANOG+ or CH+ and KLF4+ cells was similar in WT and
DHet and reduced in DKO ESCs, and the number of
OTX2+ or GFP+ and OCT6+ ESCs was severely diminished
in Otx2KO, moderately reduced in DHet, and massively
increased in DKO ESCs (Figures 2D and 3B; Table S2). We
next analyzed how these abnormalities in cell number
affected the size of ESC sub-type compartments. Compared
withWT,DHet ESCs exhibited amoderate expansion of the
naive-like compartment and a corresponding contraction
of the pre-naive-like sub-type; Otx2KO ESCs lacked the
pre-primed-like sub-type and displayed a significant reduc-
tion of the primed-like and pre-naive-like compartments,
which was counterbalanced by the marked expansion of
the naive-like sub-type; and DKO ESCs lacked the naive-
like sub-type and heavily expanded the size of the
primed-like compartment (Figures 3C, 3D, and S3C;
Table S2). Noteworthy, DKO ESCs, like Nanog null ESCs
(Figures 1K and S2J), showed a small new sub-type co-
expressing CH, GFP, and OCT6 (Figures 3C and 3D). These
data were further corroborated by the expression of addi-
tional markers and signaling effectors. Compared with
WT, naive markers such as Klf4, Esrrb, Rex1, the phosphor-
ylated form of the LIF signaling effector STAT3 (p-STAT3)
and the phosphorylated form of the bCATENIN (p-bCAT)
were almost unaffected in DHet, downregulated in DKO,
and several of them such as p-STAT3, Esrrb, Klf4, andithOCT4andKLF4andwith CDX2,GATA4, andOCT4. Scale bar, 100mm.
d Igf2) markers on WT and NanogKOS RNAs normalized by b-Actin
with OCT4 and OCT6, with NANOG or CH, OTX2, and OCT4 and with
bar, 100 mm.
rcentage of total cells expressing OCT4 (F), the percentage of OCT4+
entage of total cell sub-types showing naive-like, pre-naive-like,
rcentage of total cells expressing the sum of all cell sub-types (I).
***p 0.001; **p < 0.001; *p value is between 0.005 and 0.001.
Oct6, Fgf4 Rex1, and Esrrb in WT, NanogKO, and NanogKOS RNAs
ing that NanogKOS ESCs exhibit a reduction of the naive-like
-like, and primed-like compartments. A color code of the different
Stem Cell Reports j Vol. 9 j 1642–1659 j November 14, 2017 1645
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Rex1, were upregulated inOtx2KO ESCs (Figures 2E, 2F, and
S4C). Primed markers such as T and p-ERK1,2 were upregu-
lated in DKO, while in Otx2KO and DHet ESCs, p-ERK1,2
was downregulated (Figures 2E, 2F, and S4C). These data
indicate that (1) in contrast to Nanog null ESCs, loss of
Nanog in an Otx2 null background generates a compensa-
tory effect resulting in a restored LIF-dependent self-
renewal and suppression of PE-like differentiation, and
(2) in contrast toOtx2KO, the identity ofDKO ESCs exhibits
a marked expansion of the primed-like compartment.
Overall, these data suggest that NANOG and OTX2 coop-
erate through their antagonistic transcriptional networks
to specify and maintain the identity of ESCs cultured in
LIF + FBS.
Identity Assignment of DKO and Otx2KO ESCs by
Transcriptome Analysis
To evaluate the identity of DKO and Otx2KO cells, we used
global transcriptome analyses. We compared DKO and
Otx2KO ESCs cultured in LIF + FBS with WT ESCs cultured
in LIF + 2i, LIF + FBS, or in FGF2 + Activin A for 44 hr to
generate EpiLCs (44 hr) (Figures 4 and S5; Tables S3–S5).
We first performed pairwise analysis of DKO ESCs (LIF +
FBS) and WT EpiLCs (44 hr) both compared with WT
ESCs (LIF + FBS) or WT ESCs (LIF + 2i) to identify DKO
ESCs transcripts in common with or differentially ex-
pressed in WT EpiLCs (Figures S5A–S5D; Tables S3–S5).
These data were integrated to generate comparative Venn
diagrams showing that DKO exhibited 999 (632 upregu-
lated and 367 downregulated) transcripts in common
with those specifically expressed in WT EpiLCs (44 hr)
(box [j] highlighted by red circle in Figures 4A and 4B;
Tables S3–S5). In contrast, DKO shared only 360 and 208
differentially expressed genes with those specifically
expressed in WT ESCs (LIF + FBS) and WT ESCs (LIF + 2i),
respectively (box [j] highlighted by red circle in Figures
4C, 4D, S5M, and S5N; Tables S3–S5). RT-PCR assays
validated a number of DKO ESC (LIF + FBS) transcripts
selectively up- or downregulated in WT EpiLCs (44 hr) or
WT ESCs (LIF + FBS) (Figures 4I, 4J, S5I, and S5J). These
data suggest that DKO ESCs exhibit a transcriptome profile
with a marked signature in common with WT EpiLCsFigure 2. NANOG and OTX2 Antagonism Controls the Identity and S
(A and B) Number of DKO colonies with efficient self-renewal (A) and n
ESCs (B). Data are reported as means ± SD of four independent exper
(C) Representative images showing that DHet and DKO trypsinized ESCs
(D) Representative immunohistochemistry assays performed in WT, DH
CH, OTX2 or GFP and OCT6, and with NANOG or CH, KLF4 and OCT6; ES
(E and F) Western blots (E) and RT-PCR assays (F) performed on WT, DH
STAT3, p-ERK1,2, ERK1,2, activated-bCAT and p-bCAT (E) as well as C
internal standard (n = 3 independent experiments).
See also Figures S1 and S4.(44 hr). A similar analysis was performed for the transcrip-
tome of Otx2KO ESCs (LIF + FBS). Pairwise analysis of
Otx2KO ESCs (LIF + FBS) and WT ESCs (LIF + 2i) both
compared with WT EpiLCs (44 hr) (Figures S5E and S5F),
and pairwise analysis of Otx2KO ESCs (LIF + FBS) and WT
ESCs (LIF + FBS) both compared with WT ESCs (LIF + 2i)
(Figures S5G and S5H) were performed to identify the
Otx2KO ESCs (LIF + FBS) transcriptome fraction in com-
mon with or differentially expressed in WT ESCs (LIF +
2i) or WT ESCs (LIF + FBS). Comparative Venn diagrams
showed that, although the highest overlap was with WT
ESCs (LIF + FBS), specific transcripts (box [j] highlighted
by red circle in Figures 4E and 4F), Otx2KO ESCs (LIF +
FBS) also showed 215 gene transcripts in common with
those specifically downregulated in WT ESCs (LIF + 2i)
(box [j] highlighted by red circle in Figure 4H). Otx2KO
ESCs (LIF + FBS) shared very few differentially expressed
transcripts (n = 55) with WT EpiLCs (44 hr) (box [j] high-
lighted by red circle in Figures S5O and S5P). This suggests
that OTX2 is required to activate genes repressed by LIF + 2i
in WT ESCs. These data were also validated by RT-PCR
assays (Figures 4K, 4L, S5K, and S5L). Then we compared
the transcriptome of DKO ESCs (LIF + FBS) with that of
Otx2KO ESCs (LIF + FBS). We identified 4,209 differentially
expressed transcripts, which included 264 of the 500 genes
reported as those more sensitive to NANOG (Festuccia
et al., 2012) (Figure S5Q; Table S3, sheet 25). Based on
this, we compared these 500 NANOG-sensitive genes
(250 up- and 250 downregulated) with the OTX2-sensitive
genes (230 up- and 378 downregulated) previously identi-
fied (Table S3, sheets 19 and 20). Pairwise analysis showed
an overlap of 82 genes (Figure S5R), which included
18 genes downregulated in Nanog null and upregulated in
Otx2KO ESC lines, 58 genes with the opposite expression
profile and 6 genes downregulated in both Nanog and
Otx2 null ESCs (Table S3, highlighted in sheet 26). Note-
worthy, 17 of the 18 genes were in common with those
selectively upregulated in WT ESCs (LIF + FBS) and
included Klf4 and Tbx3, which are required to maintain
pluripotency (Niwa et al., 2009); on the other hand,
23 out of the 58 genes were shared with those selectively
upregulated in WT EpiLCs (44 hr). This suggests that theize of ESC Sub-type Compartments and Influences Self-Renewal
umber of ESC colonies uniformly stained with ALP in WT and mutant
iments. ***p 0.001.
exhibit mirror distribution of GFP+ and CH+ cells. Scale bar, 100 mm.
et, DKO, and Otx2KO ESCs with OTX2 or GFP and OCT4, with NANOG or
Cs are also stained with DAPI. Scale bar, 100 mm.
et, Otx2KO, and DKO ESCs to assess the expression level of p-STAT3,
h, Gfp, Esrrb, Klf4, Rex1, and T (F). b-Actin is used as quantitative
Stem Cell Reports j Vol. 9 j 1642–1659 j November 14, 2017 1647
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antagonism between OTX2 and NANOG may depend, at
least in part, on opposing transcriptional regulation ex-
erted directly or indirectly by these two transcription
factors on a limited number of common target genes.
DKO ESCs Colonize Preimplantation Embryos with
Reduced Efficiency
We next examined whether DKO ESCs may colonize host
blastocysts and be maintained in postimplantation
embryos and/or adult mice. The contribution frommutant
ESCs was assessed by immunostaining with the ER anti-
body recognizing R26-driven constitutive expression of
CreER (Figure S1), PCR assays, and coat-color inspection.
DHet and DKO ESCs cultured in LIF + FBS or in LIF + 2i
up to P5 were injected into E2.5 host embryos, which
were allowed to develop in vitro for 24–30 hr before implan-
tation.We found that, in contrast withDHet,DKO ESCs did
not generate evident chimerism in E12.5 embryos and
mice (Figure S6A). This may be contributed by intrinsic
loss of their preimplantation colonizing ability and/or
loss of pluripotency. To rule out the last possibility, we
analyzed DKO teratomas and found that they generated
derivatives of all germ layers (Figure S6B). Then, we studied
the colonization efficiency of DKO ESCs in preimplanta-
tion embryos. Mutant ESCs were injected at E2.5 in WT
embryos cultured up to day 4.75 and tracked using CreER
immunofluorescence. Cell counting of ER+ ESCs versus
DAPI+ total cells showed that, compared with DHet and
Otx2KO, DKO ESCs were less efficiently integrated into
host embryos (Figure 5A; Table S6). Then we studied the
identity of both injected mutant ESCs and cells of the
host embryos. We first determined the percentage of ER+
cells expressing NANOG or CH and OTX2 or GFP. We
found that comparedwithDHet, the percentage of ER+ cells
expressing NANOG or CH was increased in Otx2KO and
diminished in DKO ESCs, while the percentage of ER+ cells
expressing GFP was significantly increased in Otx2KO and
DKO ESCs (Figures 5B and 5E; Table S6). When extended
to KLF4, GATA4, OCT6, and CDX2, this analysis showed
that compared with DHet ESCs, the percentage of ER+ cells
expressing KLF4 was remarkably diminished in blastocysts
injected with DKO ESCs; ER+ cells co-expressing OCT6 orFigure 3. Cell-Counting Analysis of Mutant ESC Sub-type Compar
(A–C) Cell-counting data showing for WT, DHet, DKO, and Otx2KO ESCs
OCT4+ cells expressing NANOG or CH, KLF4, OCT6 and OTX2 or GFP (B
naive-like, pre-naive-like, unassigned, pre-primed-like, primed-like c
(CH+-GFP+-OCT6+) (C). Data are reported as the means ± SD from four
between 0.005 and 0.001.
(D) Schematic representation of ESC compartments showing that Otx2
counterbalanced by a significant contraction of the pre-naive-like and
of the naive-like compartment and expansion of primed-like and pre-
See also Figure S3 and Table S2.GATA4 or CDX2 were not detected (Figures 5B and 5E;
Table S6). This analysis suggests that the host environment
slightlymodifies the expression ofNANOGorCH,OTX2 or
GFP and KLF4 described in vitro for mutant ESCs, while it
efficiently prevents/suppresses OCT6. These data were
further confirmed by determining the percentage of total
cells co-expressing ER with NANOG or OTX2 or KLF4
(Figure 5C; Table S6). Then, we studied whether the per-
centage of total cells expressing NANOG, OTX2, or KLF4
in host cells (ER) was affected. For these markers, this per-
centage was slightly increased only in blastocysts injected
with DKO ESCs (Figures 5D and 5E; Table S6), suggesting
that it may be a consequence of the reduced colonizing
ability of DKO ESCs.
Otx2 Overexpression Is Sufficient to Induce Early
Primed-like Identity in ESCs Cultured in LIF without
the Contribution of FGF
Transition of ESCs into early primed pluripotency is charac-
terized by rapid and wide activation of OTX2 and OCT6
(Acampora et al., 2016). Therefore, we investigated
whether ubiquitous activation of OTX2 in ESCs cultured
in LIF + FBS was sufficient to impart an early primed-like
identity similar to that observed when FGF2 was adminis-
tered to WT ESCs. To this aim, we generated a further
mutant ESC line (pPyCAGOtx2-ER) showing constitutive
expression of a fusion protein between OTX2 and
ERT2 (OTX2-ER) (Figure S7A). Western blot analysis of
the Tx-untreated pPyCAGOtx2-ER selected clone (red arrow
in Figure S7B) showed that the amount of the OTX2-ER
fusion proteinwas about four times that of the endogenous
OTX2. Assuming that the endogenousOTX2was expressed
in about 40% of ESCs and that the OTX2-ER protein is pre-
sent in all ESCs, we concluded that the OTX2-ER level/cell
should be about two times that of the endogenous OTX2.
Shortly after Tx administration, OTX2-ER was translocated
to the nucleus (Figure S7C). Compared with WT, in
pPyCAGOtx2-ER ESCs, the distribution and/or expression
level of a number of markers including NANOG, OCT4,
KLF4, OCT6, Esrrb, Rex1, Fgf5,T, Foxa2, and Sox1was appar-
ently not influenced by OTX2-ER when Tx was absent
(Figures 6A, 6B, and S4D). However, when Tx was addedtments
the percentage of total cells expressing OCT4 (A), the percentage of
), and the percentage of total cells (OCT4+), corresponding to the
ompartments (C); note that DKO ESCs show a new small sub-type
independent experiments. ***p 0.001; **p < 0.001; *p value is
KO ESCs exhibit a relevant expansion of the naive-like compartment
loss of the pre-primed-like compartments; and DKO ESCs show loss
primed-like compartments.
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to LIF + FBS-containing medium, nuclear translocation of
OTX2-ER induced a profound change in the identity
of ESCs, which exhibited marked similarity with WT
ESCs primed with FGF2 (Figure 6A). Indeed, Tx-treated
pPyCAGOtx2-ER ESCs (LIF + FBS) and WT ESCs exposed
to FGF2 in KSR retained an ubiquitous distribution of
OCT4 and exhibited a relevant contraction of NANOG+
and KLF4+ cells counterbalanced by the expansion of
OCT6+ cells (Figures 6A, 6C, 6D, and S7D; Table S2).
Analysis of ESC sub-types showed that in Tx-treated
pPyCAGOtx2-ER ESCs, the naive-like sub-type was lost,
the pre-naive-like sub-type was reduced, and the primed-
like sub-type was expanded (Figures 6E and 6F; Table S2).
Importantly, FGF2-mediated priming of WT ESCs in-
duced a similar organization of sub-type compartments
(Figures 6E and 6F; Table S2). Moreover, in Tx-treated
pPyCAGOtx2-ER ESCs, additional naive factors such as Esrrb
and Rex1 were downregulated, whereas primed markers
such as Fgf5, T, and Foxa2 were upregulated (Figures 6B
and S4D). Noteworthy, when Tx administration was inter-
rupted at P1, the expression of NANOG, OTX2, OCT4,
KLF4, and OCT6 reverted and, at P3, was very similar to
that of WT ESCs (Figure S7E). These findings were
confirmed in a second independent clone (black arrow in
Figure S7B) (data not shown). These data indicate that in
LIF + FBS medium, OTX2 is sufficient, without the contri-
bution of FGF2, to induce an expansion of the primed-
like ESC compartment as observed in FGF2-primed WT
ESCs and NanogKO ESCs in LIF + FBS medium. Then, we
analyzed the response to FGF2 of NanogKOS, DKO, and
Otx2KO ESCs. Indeed, on the basis of their identity in
LIF + FBS, the NanogKOS and DKO ESCs should be primed
more efficiently than Otx2KO ESCs. Consistently, when
compared with WT, NanogKOS and DKO cells exhibited
higher induction of OCT6 and lower expression of CH,
while Otx2KO cells induced OCT6 in fewer cells and
retained a higher number of NANOG+ cells (Fig-
ure S7F). OTX2 or GFP were detected in most of the
NanogKOS and Otx2KO cells and virtually in all DKO cells
(Figure S7F). We next analyzed the identity of Tx-treated
pPyCAGOtx2-ER ESCs in chimeric blastocysts. We found
that the percentage of total cells expressing ER was notFigure 4. Analysis of DKO and Otx2KO Transcriptomes
(A–H) Venn diagrams showing the different categories of gene tr
downregulated in DKO (A–D) and Otx2KO (E–H) ESCs in LIF + FBS when
(44 hr); this analysis allows us to identify DKO (LIF + FBS) gene transcri
(44 hr) or WT ESCs (LIF + FBS) (red circle in box [j] in A–D); the same an
shared with those specifically expressed in WT ESCs (LIF + FBS) and W
(I–L) RT-PCR assays of selected genes up- or downregulated specificall
and WT ESCs (LIF + FBS) (J), or in Otx2KO (LIF + FBS) and WT ESCs (L
The selected genes belong to the box (j) highlighted with red circles
See also Figure S5 and Tables S3–S5.affected by Tx treatment (Figure S7G). Marker analysis
showed that, compared with Tx-untreated blastocysts, in
Tx-treated blastocysts, KLF4 and NANOG were detected
in a reduced percentage of ER+ cells, OCT6 was activated
in a small but significant percentage of ER+ cells, and
GATA4 and CDX2 were detected only in ER cells (Figures
S7H and S7K; Table S6). These data were confirmed by
determining the percentage of total cells expressing
NANOG, KLF4, and OCT6 in ER+ donor cells (Figures S7I
and S7K; Table S6). The complementary analysis showed
that the percentage of total cells expressing NANOG or
KLF4 in ER host cells was not significantly affected (Fig-
ures S7J and S7K; Table S6). These findings suggest that
the wide activation of OCT6 observed in cell-culture exper-
iments is partially prevented by the host environment,
which instead is unable to recover loss of naive markers.
Loss of Otx2 and/or Nanog Affects the Responding
Competence to 2i-mediated Conversion into Naive
State
Finally, we tested whether the transition to the naive
state was affected in mutant ESCs. In WT ESCs cultured in
LIF+2i, this transitionwascharacterizedby increasedexpres-
sion of naive markers such as OCT4, NANOG, KLF4, Esrrb,
Fgf4, and Rex1 and loss of primed markers such as OTX2
and OCT6 (Figures 7A, 7B, and S4E). At P1, WT, DHet (data
not shown), and Otx2KO ESCs exhibited a stable naive-like
statewhileDKO ESCs showed smallOCT4+ colonies express-
ing KLF4, CH and, unexpectedly, GFP (Figures 7A, 7B, and
S4E). Moreover, most of the OCT4 DKO cells expressed PE
(GATA4, KLF4, Foxa2, Sox17) or trophectoderm (TE)
(CDX2, Hand1, Gata3) markers (Figures 7A, 7B, and S4E),
which was reminiscent of NanogKO and NanogKOS ESCs in
LIF + FBS. Nevertheless, under sustained culture in LIF + 2i,
DKO ESCs gradually expanded the naive-like cell fraction
and at P5 were similar toWT ESCs (Figures 7A–7C). We sug-
gest that the phenotype of DKO ESCs may reflect the fact
that, although NANOG is ablated, the simultaneous loss of
OTX2 restrains but does not suppress naive conversion. To
test this possibility, we first cultured pPyCAGOtx2-ER (-Tx)
ESCs in LIF + 2i for two passages to allow conversion into
the naive-like state and then administered Tx for a thirdanscripts (boxes from (a) to (o) in each Venn diagram) up- or
compared with WT ESCs (LIF + FBS) or WT ESCs (LIF + 2i) or WT EpiLCs
pts shared with those up- or downregulated specifically in WT EpiLCs
alysis was performed to identify Otx2KO ESCs (LIF + FBS) transcripts
T ESCs (LIF + 2i) (red circle in box [j] in E–H).
y in DKO (LIF + FBS) and WT EpiLCs (44 hr) (I), or in DKO (LIF + FBS)
IF + FBS) (K), or in Otx2KO (LIF + FBS) and WT ESCs (LIF + 2i) (L).
in the Venn diagrams (n = 3 independent experiments).
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passage. Compared with untreated pPyCAGOtx2-ER ESCs,
Tx treatment generated hypomorphic OCT4+ colonies
expressing NANOG and KLF4 and numerous OCT4 cells
showingneural specificmarkers SOX1 andTUJ1 (Figure 7D).
RT-PCR assays showed that Tx administration downregu-
lated Esrrb, Rex1, and Fgf4 expression and activated strong
Sox1 expression (Figures 7E and S4F). Then, we analyzed
NanogKOS ESCs cultured in LIF + 2i. We found that at P1,
NanogKOS ESCs exhibited small OCT4+-CH+ colonies
expressing KLF4 only in a few OCT4+ cells (Figure 7F). Note-
worthy, asobserved forGFP inDKOESCs,OTX2waspartially
suppressed also in NanogKOS ESCs. Furthermore, NanogKOS
ESCs generated a relevant number of PE-like OCT4 cells
(Figures 7F, 7G, and S4G). At P5, in contrast with DKO,
NanogKOS ESCs did not recover a naive-like phenotype
(Figures 7F, 7G, and S4G). Together these and previous find-
ings highlight the relevance of the antagonism between
NANOG and OTX2 for the control of the heterogeneous
identity of ESCs in LIF + FBS. Without integration of this
mutual antagonism, the plasticity of ESCs is lost, and the
capacity for bidirectional conversion into naive or primed
pluripotency is forced in a more unidirectional manner
either forward (primed) or reverse (naive), which is estab-
lished by the dominance of the OTX2 regulatory network
over that controlled by NANOG or vice versa. When both
networks are abolished, ESCs retained a degree of plasticity
sufficient to accomplish bidirectional conversion.DISCUSSION
Heterogeneity in gene expression is a typical feature of
ESCs cultured in LIF + FBS. Understanding the molecular
basis controlling this heterogeneous condition is impor-
tant to decipher the plasticity of ESCs (Smith, 2017;
Torres-Padilla and Chambers, 2014; Martinez Arias et al.,
2013; Nichols and Smith, 2009, 2011; Chambers et al.,
2007). Although different mechanisms may operate
together to determine the final state of ESCs, the control
exerted by specific transcription factors may have a prom-
inent role. In this context, allelic control of NANOGdosage
has been proposed to have a causative role for the heteroge-Figure 5. Abnormalities of Mutant ESCs in Chimeric Blastocysts
(A) Graphic representation showing that, compared with DHet and Ot
embryos. Data are the means ± SD from n = 10 blastocysts for each E
(B–D) Cell counting showing the percentage of ER+ donor cells express
percentage of total cells (DAPI+) expressingNANOG,OTX2, or KLF4 in the
from n = 7 blastocysts for each combination of antibodies reported in
(E) Representative confocal images of embryos injected at E2.5 with DH
NANOG and OTX2, or CH and GFP, or KLF4 and OCT6, or GATA4, or CDX2. N
better view of the inner cell mass. DAPI staining is also shown. Scale
See also Figure S6 and Table S6.neity of ESCs cultured in LIF + FBS (Torres-Padilla and
Chambers, 2014; Miyanari and Torres-Padilla, 2012). On
the other hand, OTX2 exhibits heterogeneous expression
in ESCs cultured in LIF + FBS and is required to promote
the transition into the early primed state (Acampora
et al., 2013, 2016; Buecker et al., 2014; Yang et al., 2014).
These previous findings led us to investigate the possibility
that OTX2 and NANOGmay be antagonistic determinants
that together specify the heterogeneity of ESCs cultured in
LIF + FBS.We therefore studied how these two factors influ-
ence the identity and size of ESC sub-type compartments to
assess whether they privilege or affect specific states of
pluripotency co-existing in ESCs self-renewing in LIF +
FBS. To this aim, we analyzed an allelic series of mutant
ESCs carrying different dosages of OTX2 and/or NANOG.
We have shown that, without the addition of exogenous
factors that promote naive or primed pluripotency, loss of
Otx2 causes expansion of the naive-like compartment,
which is consistent with previous data on Nanog overex-
pression (Chambers et al., 2003). In contrast, loss of Nanog
analyzed inNanogKO ESCs orOtx2 overexpression generate
a strikingly similar phenotype characterized by remarkable
contraction of the naive-like compartment and expansion
of the primed-like sub-type. When both genes are deleted,
ESCs acquire a pluripotent state exhibiting identity features
in common with early primed-like cells. These data indi-
cate that antagonism between NANOG and OTX2 is an
essential requirement to specify and maintain ESC hetero-
geneity, which we visualize through the analysis of OCT4+
cells co-expressing different combinations of NANOG,
OTX2, and OCT6 (Acampora et al., 2016). We envisage
that between naive-like and primed-like compartments,
there are at least three transitional and dynamic compart-
ments—the pre-naive-like, the pre-primed-like, and the
unassigned—ready to be converted and stabilized into
naive or primed pluripotent states. Therefore, in addition
to previous studies indicating that NANOG and OTX2 are
important coordinators of naive and primed pluripotency,
respectively (Acampora et al., 2013, 2016; Buecker et al.,
2014; Yang et al., 2014; Silva et al., 2009; Chambers et al.,
2003, 2007; Mitsui et al., 2003), our new data suggest
that the combined action of these two transcription factorsx2KO, DKO ESCs exhibit reduced efficiency of integration into host
SC line; ***p 0.005.
ing NANOG, OTX2, CH, GFP, KLF4, OCT6, GATA4, and CDX2 (B) or the
donor (ER+) (C) or in thehost cells (ER) (D). Data are themeans± SD
(E) and for each ESC line. *p < 0.05; **p < 0.01; ***p < 0.005.
et, DKO, and Otx2KO ESCs and immunostained at E4.75 with ER plus
ote that the externalmost plane of acquisition is removed to allow a
bar, 30 mm.
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Figure 6. Otx2 Overexpression Is Sufficient to Prime ESCs in LIF-Containing Medium and without FGF2 Contribution
(A) Representative images of pPyCAGOtx2-ER ESCs administered or not with Tx and WT ESCs primed with FGF2 immunostained with NANOG,
OTX2, and OCT6 and with NANOG, OCT4, and KLF4. Scale bar, 100 mm.
(legend continued on next page)
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is instrumental in determining the heterogeneous identity
of ESCs cultured in LIF + FBS. Importantly, a similar hetero-
geneity can be identified in vivo between E4.5 and E4.7
when the naive pluripotency circuit is being shut down
but before the early primed state becomes dominant.
Most of the ESC sub-types detected in LIF + FBS cultures
are present in the E4.5–4.7 epiblast (Acampora et al.,
2016).We suggest that at this stage, the transitional hetero-
geneity of the epiblast is captured in cultured ESCs by LIF +
FBS and is maintained by antagonism between OTX2 and
NANOG. These observations are relevant to the recently
elaborated concept of formative pluripotency, a state
hypothesized to interpose between naive and primed plu-
ripotency and suggested to occur abruptly (Smith, 2017).
However, the finding that the epiblast of E4.5–4.7 embryos
and ESCs in LIF + FBS exhibit a spectrum of distinct and
precise combinations of naive and primed markers leads
us to suggest that this transition may not necessarily occur
abruptly. In this context, an imbalance in favor of the
OTX2-dependent regulatory network due to downregula-
tion of Nanog expression and upregulation of Otx2 might
trigger conversion of pluripotency from a metastable and
heterogeneous condition toward a formative state.
The co-existence of different pluripotent sub-types is an
intermediate gate preceding the unidirectional transition
of the epiblast into the early primed state in vivo, and allow-
ing bidirectional conversion into naive or early primed
state in vitro (Smith, 2017; Torres-Padilla and Chambers,
2014; Martinez Arias et al., 2013; Nichols and Smith,
2011; Silva et al., 2009; Ying et al., 2008). The capability
of NANOG to impose a unimodal naive-like identity is
counterbalanced by OTX2, which, in turn, promotes
primed-like identity. We propose that integration of these
opposing regulatory circuits underlies the mechanism
that specifies heterogeneity in ESCs. This identity can be
established only in LIF-containing medium where exoge-
nous signal constraints (FGF or 2i) are minimized and
ESCs are allowed tomanifest their flexible nature. Signaling
pathway activation perturbs this state and determines the
dominance of one of the two regulatory networks. This
process requires the contemporary and co-ordinated
response by both NANOG and OTX2. Indeed, 2i-mediated
induction of naive state could not be efficiently accom-(B) Representative RT-PCR assays show that in WT and pPyCAGOtx2
OTX2-ER downregulate Nanog, Klf4, Esrrb, and Rex1 and upregulate end
(C–E) Cell counting showing for WT ESCs (LIF + FBS), Tx-treated pPyCAG
total cells expressing OCT4 (C), the percentage of OCT4+ cells expressi
cells (OCT4+) expressing the different sub-types identified by the comb
as means ± SD from four independent experiments. ***p 0.001; *
(F) Cell-counting data show that nuclear translocation of OTX2-ER i
similar to that induced by FGF2 in WT ESCs.
See also Figures S4 and S7 and Table S2.plished without Nanog activation and Otx2 repression;
similarly, FGF-mediated induction of primed state is
incomplete without Otx2 activation and Nanog downregu-
lation. Specification and maintenance of this mechanism
require that the dosage and expression pattern of OTX2
and NANOG should be established within precise parame-
ters, which ultimately determine the degree of integration
between their antagonistic transcriptional networks.
According to a hierarchically high role of OTX2 and
NANOG in interpreting and responding to primed and
naive inducers, we report that transitions between naive
and primed compartments can be coherently mimicked
in LIF + FBS only by genetic manipulations of OTX2 and/or
NANOG dosage.EXPERIMENTAL PROCEDURES
Generation of ESC Lines
All mutant ESC lines (Figure S1) were generated in an E14Tg2a-
derived ESC line, whose Rosa26 locus was previously targeted
with aCreER-pac gene cassette (Acampora et al., 2013). The sequen-
tial steps for the generation of mutant ESCs are described in the
Supplemental Experimental Procedures.
Cell-Culture Experiments
ESC culture procedures are described in the Supplemental Experi-
mental Procedures.
RT-PCR and Western Blotting
RT-PCRs were performed in non-saturating conditions using the
primers and cycles listed in Table S7. Western blots were probed
with antibodies and at the dilutions listed in Table S7.
FACS Analysis
NanogKO ESCs were trypsinized, centrifuged, and resuspended
in ESC medium containing 2% FBS and 2 mM EDTA. The CH+
fraction was sorted using a BD FACSAria III (Becton Dickinson)
into a 6-well plate. The data were analyzed using the BD FACSDiva
software.
Immunohistochemistry
Immunohistochemistry assays on ESCs and embryos and ALP
assays were performed as described (Acampora et al., 2013).
Antibodies and dilutions used in this study are listed in Table S7.-ER ESCs, FGF2 treatment and Tx-induced nuclear translocation of
ogenous Otx2, Fgf5, T, and Foxa2 (n = 3 independent experiments).
Otx2-ER in LIF + FBS, and WT ESCs in KSR plus FGF2 the percentage of
ng NANOG or KLF4 or OCT6 or OTX2 (D), and the percentage of total
inatorial analysis of NANOG, OCT6, and OTX2 (E). Data are presented
*p < 0.001; *p value is between 0.005 and 0.001.
s sufficient to induce a re-organization of sub-type compartments
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RNA-Seq Experiments, Analysis of RNA-Seq Data, and
RNA-Seq Validation Assays
RNA-seq experiments were performed on DKO ESCs (LIF + FBS),
Otx2KO ESCs (LIF + FBS), WT ESCs (LIF + FBS), WT ESCs (LIF + 2i),
and WT EpiLCs (44 hr). Indexed sequencing libraries were gener-
ated and analyzed as described in the Supplemental Experimental
Procedures.
Chimerism Experiments
Chimerism experiments are described in the Supplemental Exper-
imental Procedures. Animals were handled in accordance with the
authorization 1196/2015-PR released by the Italian Ministry of
Health.
Cell-Counting Experiments
Cell counting of ESC sub-types was manually performed on
immunohistochemistry images printed in A4 format (Acampora
et al., 2013, 2016). SD was calculated from the analysis of four
independent experiments. p values were determined using the
one-tailed Student’s t test. Cell counting of chimeric blastocysts
was performed on n = 10 blastocysts for colonization efficiency
experiments and on n = 7 blastocysts for each combination of
antibodies and for each injected ESC line (Table S6). Images
were printed in A4 format for manual cell counting. Data are
reported as means ± SD; p values were determined using the
one-tailed Student’s t test. For details see Supplemental Experi-
mental Procedures.
ACCESSION NUMBERS
RNA-seq data are available in European Nucleotide Archive
database (https://www.ebi.ac.uk/ena/submit/sra/#home) under
accession number ENA: PRJEB19241/ERP021225.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and seven tables and can be foundFigure 7. Conversion of Mutant ESC Lines into Naive-like and Pri
(A) Representative immunohistochemistry assays with OTX2 or GFP an
at passage (P) 1, P2, and P5 in WT, Otx2KO, and DKO ESCs cultured in
ubiquitous expression of OCT4, KLF4, and CH and stop generating OC
(B) RT-PCR assays show that in DKO ESCs, the expression of naive, PE,
ESCs (n = 3 independent experiments).
(C) Western blots show that at P5 also the level of p-STAT3, p-ERK
independent experiments).
(D) Representative immunohistochemistry assays with OTX2 and NA
cultured in LIF + 2i up to P3 without Tx or cultured up to P2 without
(E) RT-PCR assays of Tx-treated pPyCAGOtx2-ER ESCs show reduced exp
of PE, TE, and primed markers appear unaffected (n = 3 independent
(F) Representative immunohistochemistry assays with OTX2 and NA
NanogKOS ESCs cultured in LIF + 2i exhibit small and rare OCT4+ colo
GATA4, and do not recover a naive-like phenotype at P5.
(G) RT-PCR assays performed on WT and NanogKOS ESCs cultured in L
stably upregulated, TE markers are transiently upregulated, and prim
See also Figure S4.with this article online at https://doi.org/10.1016/j.stemcr.2017.
09.019.
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